Ademi LLP is investigating At Home (NYSE: HOME) for possible breaches of fiduciary duty and other violations of law in its transaction with Hellman & Friedman.
Ademi LLP alleges At Home’s financial outlook is excellent and yet At Home shareholders will receive only $36 per share in cash. The merger agreement unreasonably limits competing bids for At Home by prohibiting solicitation of further bids, and imposing a termination penalty if At Home accepts a superior bid. At Home insiders will receive millions of dollars as part of change of control arrangements. We are investigating the conduct of At Home’s board of directors, and whether they are (i) fulfilling their fiduciary duties to all shareholders, and (ii) obtaining a fair and reasonable price for At Home.